TrialGynecologic oncology2020

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.

Warner K Huh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.